We urge Congress to take action on Senate bill 214, the Preserve Access to Affordable Generics Act.
I think that there would be benefits of billions of dollars from outlawing these reverse payment settlements.
Pay-for-delay settlements are the most egregious form of antitrust violation in my mind.
The CBO, as we know, expects this legislation would accelerate the availability of generic drugs and save $4.7 billion over 10 years.
You have an FTC which probably does not have the resources to match yours and the pharmaceutical industry.
Many more cases settle without pay-for-delay than with pay-for-delay.
It seems to me the evidence suggests that just putting it back to rule of reason should have--should do the trick based on the evidence that...
we need this to have the Justice Department function.
we were ministers of justice and that we did our job best when we had worthy opponents.
we really do believe we need functioning courts.
So that is why we were coming up, Senator Grassley and I, with a way to sort of even the playing field.